Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in SGMT — Sagimet Biosciences Inc.

CIK 1037389 NEW YORK, NY
Back to SGMT Full portfolio

Position in SGMT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,681,745
-$586,330 QoQ
Shares Held
346,927
-44.5% QoQ
Ownership
0.558%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 122 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. SGMT ranks #112 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in SGMT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,681,745 346,927
2026-03-31 $3,268,075 625,469
2025-12-31 $2,027,600 342,500
2025-09-30 $1,107,204 161,400
2025-06-30 $235,458 30,900
2024-12-31 $48,600 10,800
2024-09-30 $640,147 231,100
2024-06-30 $829,008 242,400
2024-03-31 $2,273,148 419,400
2023-12-31 $124,660 23,000